An interventional study of Functional Electrical Stimulation and Conventional physiotherapy in Intensive Care Unit (ICU) Acquired Weakness (ICU - AW) and Acquired Brain Injury (Including Stroke), sponsored by Fondazione Don Carlo Gnocchi ETS. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-12-11.
Sponsored by Fondazione Don Carlo Gnocchi ETS · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 76 studies in Brain Injuries with a site in Italy — 27 open to participants now, 29 under way, none of them phase 3. Brain Injuries · Italy.
Among the 76 studies in Brain Injuries with a site in Italy, this one is the 31st largest by planned enrollment of the 48 interventional ones that give a count, is one of 8 that started in 2025, is one of 43 with no phase, reaches primary completion later than 13 of the 28 other live ones, and was the 67th registered.
947 studies on the registry are indexed under Brain Injuries; 234 are open to participants now.
Browse Brain Injuries studies →27 of the 76 studies in Brain Injuries with a site in Italy are open now. Recruiting first, the newest first:
Fondazione Don Carlo Gnocchi ETS · Sites in Italy
Ages 18+
Alfonso Magliacano · Sites in Italy
Ages 18–75 · Healthy volunteers
IRCCS Eugenio Medea · Sites in Italy
Ages 6–14
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages 18–80
Erasme University Hospital · Sites in Italy, Belgium
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 152 Brain Injuries studies recruiting now, 77 (51%) set no upper age limit and 53 (35%) stop at 75 or younger; 38 take children under 18; 23 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
76 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 8 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 24 is below the median of 41 across 613 interventional studies indexed under Brain Injuries.
Median enrollment 40 across the 48 interventional studies, 88 across the 28 observational. Of the 35 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 76 have an industry lead sponsor. The 10 most frequent:
Fondazione Don Carlo Gnocchi ETS is the lead sponsor of 43 studies on the registry; 26 are open to participants now.
Fondazione Don Carlo Gnocchi ETS has 2 studies filed under Brain Injuries — fewer than ten, so there is no comparison to draw.
7 of the studies in Brain Injuries with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06823193Istituti Clinici Scientifici Maugeri SpAThe Impact of Self-processing on Mental Time Travel | 2026-12-30 |
| NCT07490418B&B srlTES HT100 Clinical Validation for Brain Injury Screening in Patients With Mild Head Trauma or Neurological Symptoms | 2026-12-30 |
| NCT06873477Fondazione Policlinico Universitario Agostino Gemelli IRCCSEvaluation of Patients Affected by Traumatic and Hypoxic-ischemic Brain Injury | 2027-01-31 |
| NCT05493514Fondazione Don Carlo Gnocchi OnlusClinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System | 2027-04-01 |
| NCT04905264Mario Negri Institute for Pharmacological ResearchSevere Acquired Brain Injuries: Prognostic Factors and Quality of Care | 2027-06 |
Add all 7 to your calendar (.ics) → With an account.
Among the 76 studies in Brain Injuries with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to evaluate the effectiveness of physiotherapy treatment combined with functional electrical stimulation (FES) in a small group of patients with severe acquired brain injury (SABI) of vascular origin and with a clinical and instrumental diagnosis of "Intensive Care Unit-Acquired Weakness" (ICU-AW). Functional electrical stimulation is a technology that uses electrical impulses, generated by an external device, to reactivate the neuromuscular system through electrodes applied to the skin. In functional electrical stimulation, this process is integrated into physiotherapy sessions, with the active involvement of the patient, through the performance of exercises with the assistance and supervision of the physiotherapist. The rationale behind this is to stimulate neuroplasticity processes by facilitating movement through the application of electrical stimuli and the active participation of the patient in performing a motor task, in an attempt to promote improvement in an impaired function.
In particular, the objectives that will be pursued are: improvement of lower limb neuromyopathy assessed clinically using the Medical Research Council (MRC) scale, the Fugl-Meyer scale for lower limbs, the Short Physical Performance Battery (SPPB) scale, the assessment of active and passive Range Of Motion (ROM) of the main joints of the lower limb (hip, knee, ankle) and measured instrumentally by neurophysiological examination and ultrasound examination.
After randomization, patients in the control arm will be treated with physiotherapy and speech therapy sessions as per the conventional protocol, and an additional 15 physiotherapy sessions lasting 60 minutes over a period of 5 weeks. Alternatively, patients in the experimental group will receive, in addition to conventional rehabilitation treatment, a treatment consisting of 15 physiotherapy sessions combined with FES lasting 60 minutes over a period of 5 weeks.
At the end of the treatment period, baseline characteristics and clinical and instrumental outcome variables will be compared between the two groups using the chi-square test for dichotomous and categorical variables and the t-test for independent samples or the Mann-Whitney U test for continuous variables, depending on whether or not they are normally distributed. In all analyses, a p-value \<0.05 will be considered significant.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Functional Electrical Stimulation
conventional physiotherapy in an equivalent additional session (without FES).
Other: Conventional physiotherapy
Physiotherapy exercises, selected from a group of active flexion-extension exercises, cycle ergometer, sit-to-stand exercises and a preparatory exercise for the gait pattern with hip flexion and subsequent loading on the lower limb, associated with functional electrical stimulation.
Conventional physiotherapy exercises, selected from a group of active flexion-extension exercises, cycle ergometer, sit-to-stand exercises and a preparatory exercise for the gait pattern with hip flexion and subsequent loading on the lower limb.
Change in lower limb neuromyopathy assessed blindly compared to the treatment/control arm at the clinical level using the Medical Research Council (MRC) scale.
Time frame: From enrollment to the end of treatment at 5 weeks from T0 (T1) and from enrollment to the follow-up at 12 weeks from T0(T2).
Change in the units of the scale "Fugl-Meyer scale for lower limbs".
Time frame: From enrollment to the end of treatment at 5 weeks (T1) and from enrollment to the follow-up at 12 weeks(T2).
Change in the units of the scale "the Short Physical Performance Battery (SPPB) scale".
Time frame: From enrollment to the end of treatment at 5 weeks from T0 (T1) and from enrollment to the follow-up at 12 weeks from T0(T2).
Change in the degrees of the active range of motion of the main joints of the lower limbs (hip, knee, ankle).
Time frame: From enrollment to the end of treatment at 5 weeks from T0 (T1) and from enrollment to the follow-up at 12 weeks from T0(T2).
Change in the degrees of passive range of motion of the main joints of the lower limbs (hip, knee, ankle).
Time frame: From enrollment to the end of treatment at 5 weeks from T0 (T1) and from enrollment to the follow-up at 12 weeks from T0(T2).
Change in the parameters recorded during the neurophysiological examination using electromyography.
Time frame: From enrollment to the end of treatment at 5 weeks (T1).
Change in the parameters recorded during ultrasound examination
Change in the parameters recorded during ultrasound examination of the transverse diameter of the rectus femoris.
Time frame: From enrollment to the end of treatment at 5 weeks (T1).
Change in the parameters recorded during ultrasound examination
Change in the difference between the distance from the skin plane and the deep layer of the rectus femoris recorded with the muscle at rest and during contraction, recorded using M-mode ultrasound.
Time frame: From enrollment to the end of treatment at 5 weeks
Started Sep 2025 (actual). Primary completion is estimated for Sep 2026, 12 months after the start.
Of 285 non-industry interventional studies with no phase under Brain Injuries, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's planned 12 months is below that.
Counting every sponsor, half of 298 studies reached it within 24 months; a quarter within 12 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fondazione Don Carlo Gnocchi ETS